Search the collection

146 results for Sodium-Glucose+Transporter+2+-+antagonists+

Sort by:

Sort by

Limit results to:

20 per page

146 results for Sodium-Glucose+Transporter+2+-+antagonists+

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
New fixed combination in type 2 diabetes
Author / Creator:Red
Publisher:Germany
Journal title:MMW Fortschritte der Medizin, 2016-04, Vol.158 (7), p.74-74
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
SGLT2 inhibition in type 2 diabetes. New study data for reducing cardiovascular risk
Publisher:Germany
Journal title:MMW Fortschritte der Medizin, 2015-10, Vol.157 (18), p.86-87
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor
Author / Creator:Fralick, Michael ; Schneeweiss, Sebastian ; Patorno, Elisabetta
Publisher:United States: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2017-06, Vol.376 (23), p.2300-2302
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
Author / Creator:Gilbert, Richard E, Prof ; Krum, Henry, Prof
Publisher:England: Elsevier Ltd
Journal title:The Lancet (British edition), 2015-05, Vol.385 (9982), p.2107-2117
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
Author / Creator:DeFronzo, Ralph A. ; Norton, Luke ; Abdul-Ghani, Muhammad
Publisher:London: Nature Publishing Group UK
Journal title:Nature reviews. Nephrology, 2017-01, Vol.13 (1), p.11-26
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Author / Creator:Ferrannini, Ele ; Muscelli, Elza ; Frascerra, Silvia ; Baldi, Simona ; Mari, Andrea ; Heise, Tim ; Broedl, Uli C. ; Woerle, Hans-Juergen
Publisher:United States: American Society for Clinical Investigation
Journal title:The Journal of clinical investigation, 2014-02, Vol.124 (2), p.499-508
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System
Author / Creator:Fadini, Gian Paolo ; Bonora, Benedetta Maria ; Avogaro, Angelo
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Diabetologia, 2017-08, Vol.60 (8), p.1385-1389
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 n...
Author / Creator:Cefalu, William T, Prof ; Leiter, Lawrence A, Prof ; Yoon, Kun-Ho, Prof ; Arias, Pablo, Prof ; Niskanen, Leo, Prof ; Xie, John, PhD ; Balis, Dainius A, PharmD ; Canovatchel, William, MD ; Meininger, Gary, MD
Publisher:Kidlington: Elsevier Ltd
Journal title:The Lancet (British edition), 2013-09, Vol.382 (9896), p.941-950
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE−/− mice fed a western diet
Author / Creator:Han, Ji Hye ; Oh, Tae Jung ; Lee, Ghayoung ; Maeng, Hyo Jin ; Lee, Dong Hwa ; Kim, Kyoung Min ; Choi, Sung Hee ; Jang, Hak Chul ; Lee, Hye Seung ; Park, Kyong Soo ; Kim, Young-Bum ; Lim, Soo
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Diabetologia, 2017-02, Vol.60 (2), p.364-376
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
Author / Creator:Cherney, David ; Lund, Søren S. ; Perkins, Bruce A. ; Groop, Per-Henrik ; Cooper, Mark E. ; Kaspers, Stefan ; Pfarr, Egon ; Woerle, Hans J. ; von Eynatten, Maximilian
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Diabetologia, 2016-09, Vol.59 (9), p.1860-1870
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial
Author / Creator:Neal, Bruce, PhD ; Perkovic, Vlado, PhD ; de Zeeuw, Dick, PhD ; Mahaffey, Kenneth W., MD ; Fulcher, Greg, MD ; Stein, Peter, MD ; Desai, Mehul, MD ; Shaw, Wayne, DSL ; Jiang, Joel, PhD ; Vercruysse, Frank, MD ; Meininger, Gary, MD ; Matthews, David, DPhil
Publisher:United States: Mosby, Inc
Journal title:The American heart journal, 2013-08, Vol.166 (2), p.217-223.e11
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
SGLT2 inhibition — a novel strategy for diabetes treatment
Author / Creator:Chao, Edward C. ; Henry, Robert R.
Publisher:London: Nature Publishing Group UK
Journal title:Nature reviews. Drug discovery, 2010-07, Vol.9 (7), p.551-559
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesPeer ReviewedFull Text
Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
Author / Creator:Habibi, Javad ; Aroor, Annayya R. ; Sowers, James R. ; Jia, Guanghong ; Hayden, Melvin R. ; Garro, Mona ; Barron, Brady ; Mayoux, Eric ; Rector, R. Scott ; Whaley-Connell, Adam ; DeMarco, Vincent G.
Publisher:England: BioMed Central
Journal title:Cardiovascular diabetology, 2017-01, Vol.16 (1), p.9-9, Article 9
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesPeer ReviewedFull Text
Nephron Protection in Diabetic Kidney Disease
Author / Creator:Anders, Hans-Joachim ; Davis, John M ; Thurau, Klaus
Publisher:United States: Massachusetts Medical Society
Journal title:The New England journal of medicine, 2016-11, Vol.375 (21), p.2096-2098
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans
Author / Creator:Abdul-Ghani, Muhammad A. ; DeFronzo, Ralph A. ; Norton, Luke
Publisher:Alexandria, VA: American Diabetes Association
Journal title:Diabetes (New York, N.Y.), 2013-10, Vol.62 (10), p.3324-3328
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
ArticlesPeer ReviewedFull Text
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxici...
Author / Creator:Oelze, Matthias ; Kröller-Schön, Swenja ; Welschof, Philipp ; Jansen, Thomas ; Hausding, Michael ; Mikhed, Yuliya ; Stamm, Paul ; Mader, Michael ; Zinßius, Elena ; Agdauletova, Saule ; Gottschlich, Anna ; Steven, Sebastian ; Schulz, Eberhard ; Bottari, Serge P. ; Mayoux, Eric ; Münzel, Thomas ; Daiber, Andreas
Publisher:United States: Public Library of Science
Journal title:PloS one, 2014-11, Vol.9 (11), p.e112394-e112394
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
Author / Creator:Kawanami, Daiji ; Matoba, Keiichiro ; Takeda, Yusuke ; Nagai, Yosuke ; Akamine, Tomoyo ; Yokota, Tamotsu ; Sango, Kazunori ; Utsunomiya, Kazunori
Publisher:Switzerland: MDPI AG
Journal title:International journal of molecular sciences, 2017-05, Vol.18 (5), p.1083
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesPeer ReviewedFull Text
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Author / Creator:Lin, Bowen ; Koibuchi, Nobutaka ; Hasegawa, Yu ; Sueta, Daisuke ; Toyama, Kensuke ; Uekawa, Ken ; Ma, MingJie ; Nakagawa, Takashi ; Kusaka, Hiroaki ; Kim-Mitsuyama, Shokei
Publisher:England: BioMed Central
Journal title:Cardiovascular diabetology, 2014-10, Vol.13 (1), p.148-148, Article 148
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes
Author / Creator:Rosenstock, Julio ; Aggarwal, Naresh ; Polidori, David ; Zhao, Yue ; Arbit, Deborah ; Usiskin, Keith ; Capuano, George ; Canovatchel, William
Publisher:Alexandria, VA: American Diabetes Association
Journal title:Diabetes care, 2012-06, Vol.35 (6), p.1232-1238
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration
Author / Creator:Škrtić, Marko ; Yang, Gary K. ; Perkins, Bruce A. ; Soleymanlou, Nima ; Lytvyn, Yuliya ; von Eynatten, Maximilian ; Woerle, Hans J. ; Johansen, Odd Erik ; Broedl, Uli C. ; Hach, Thomas ; Silverman, Melvin ; Cherney, David Z. I.
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Diabetologia, 2014-12, Vol.57 (12), p.2599-2602
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 146 results

Export record to excel

Export this record

Export record to excel

New fixed combination in type 2 diabetes

Export this record

Export record to excel

SGLT2 inhibition in type 2 diabetes. New study data for reducing cardiovascular risk

Export this record

Export record to excel

Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor

Export this record

Export record to excel

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy

Export this record

Export record to excel

Renal, metabolic and cardiovascular considerations of SGLT2 inhibition

Export this record

Export record to excel

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Export this record

Export record to excel

SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System

Export this record

Export record to excel

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 n...

Export this record

Export record to excel

The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE−/− mice fed a western diet

Export this record

Export record to excel

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes

Export this record

Export record to excel

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial

Export this record

Export record to excel

SGLT2 inhibition — a novel strategy for diabetes treatment

Export this record

Export record to excel

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes

Export this record

Export record to excel

Nephron Protection in Diabetic Kidney Disease

Export this record

Export record to excel

Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans

Export this record

Export record to excel

The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxici...

Export this record

Export record to excel

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy

Export this record

Export record to excel

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

Export this record

Export record to excel

Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes

Export this record

Export record to excel

Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration

Refine your search